National Comprehensive Cancer Network

About NCCN

Updated Resource Offers Easy-to-Understand Information about Prostate Cancer and Its Treatment

By Laura Hanisch, PsyD, Medical Writer/Patient Information Specialist

The National Comprehensive Cancer Network® (NCCN®) has published an updated and newly redesigned NCCN Guidelines for Patients®: Prostate Cancer. This patient resource is based on the 20th annual edition of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Prostate Cancer.

The 2015 Version of the NCCN Guidelines for Patients®: Prostate Cancer includes important changes in the workup and treatment of prostate cancer. These changes include the addition of molecular testing, as well as further elaboration on the utilization of prostate MRI. In addition, continuous androgen deprivation therapy with docetaxel was added as an early-treatment option for hormone-sensitive, high-volume M1 disease. Importantly, based on user and stakeholder feedback, recommendations for proton radiation therapy and stereotactic body radiotherapy have been clarified. 

A digital version of the NCCN Guidelines for Patients®: Prostate Cancer can be downloaded free-of-charge on

NCCN currently offers NCCN Guidelines for Patients® for the following: Breast Cancer: Stages 0-IV, Colon, Esophageal, Non-Small Cell Lung, Ovarian, Pancreatic, and Prostate Cancers; Acute Lymphoblastic Leukemia; Caring for Adolescents and Young Adults (AYA); Chronic Myelogenous Leukemia; Malignant Pleural Mesothelioma; Melanoma; Multiple Myeloma; Lung Cancer Screening; and Soft Tissue Sarcoma.

NCCN is committed to developing a comprehensive patient library with support from the NCCN Foundation®.